The traditional model of health care treatment of ‘one size fits all’ is being superseded by personalised medicine. Personalised medicine represents an important evolution in healthcare practice by tailoring the treatment to the individual patient, helping to get more value from healthcare spending. In order to achieve this goal, personalised medicine relies on the use of biomarkers and of appropriate diagnostic methods.
This one-day seminar will provide an up-to-date overview of the regulatory framework. Expert speakers from the EMA, national regulatory authorities and from industry will highlight the key considerations for the development of new products.